Ahmed Kotb, MD
Ahmed Kotb, MD
As Head of Global Oncology Medical Affairs, Ahmed Kotb, MD, plays a critical role in informing development and commercialization through integration of clinical, patient and scientific insights, leading global medical launch readiness for the scientific community and understanding patient experiences.
Dr. Kotb brings over 25 years of combined clinical and pharmaceutical experience to Daiichi Sankyo. His clinical career has focused on transplant and clinical nephrology, and his industry experience spans multiple oncology medicines including monoclonal antibodies, antibody drug conjugates, bispecific antibodies, kinase inhibitors and various targeted agents across various phases of development and in multiple tumor types.
Dr. Kotb is passionate about providing tailored evidence, education and innovative healthcare solutions fit for purpose to different care settings that truly impact overall cancer patient outcomes.